Common use of Financial Arrangements Clause in Contracts

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial by the Sponsor are set out in Appendix 6 hereto. 10.2 In the event that amendments to the Protocol require changes to the trial financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 on presentation of a VAT invoice from the Trust to the Party making payment. 10.4 The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust within 45 days of the close-out of the Trial Site. The Trust will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust and the Party making payment to extend these periods. 10.5 The Party making payment shall do so within forty-five (45) days of the date of receipt of the invoice mentioned in clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial by the Sponsor are set out in Appendix 6 5 hereto. 10.2 In the event that amendments to the Protocol require changes to the trial financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 5 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 5 on presentation of a VAT invoice from the Trust to the Party making paymentSponsor by the Trust. 10.4 The Party making payment Sponsor shall promptly respond to any reasonable request for invoicing data received from the Trust within 45 days of the close-out of the Trial Site. The Trust will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment Sponsor as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust and the Party making payment Sponsor to extend these periods. 10.5 The Party making Sponsor shall make payment shall do so within forty-forty five (45) days of the date of receipt of the invoice mentioned in clause Clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party the Sponsor will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial by the Sponsor are set out in Appendix 6 hereto. 10.2 . In the event that amendments to the Protocol require changes to the trial financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 . All payments will be made according to the schedule contained in Appendix 6 on presentation of a VAT invoice from the Trust to the Party making payment. 10.4 . The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust within 45 days of the close-out of the Trial Site. The Trust will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust and the Party making payment to extend these periods. 10.5 . The Party making payment shall do so within forty-five (45) days of the date of receipt of the invoice mentioned in clause 10.3 above. 10.6 . Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial Investigation by the Sponsor are set out in Appendix 6 5 hereto. 10.2 In the event that amendments to the Protocol Clinical Investigation Plan require changes to the trial investigation financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 5 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 5 on presentation of a VAT invoice from the Trust to the Party making paymentSponsor by the Board. 10.4 The Party making payment Sponsor shall promptly respond to any reasonable request for invoicing data received from the Trust Board within 45 forty five (45) days of the close-out of the Trial Investigation Site. The Trust Board will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment Sponsor as soon as possible and, in any event, within 45 forty five (45) days of receipt of the said data where such a request has been made, or within 45 forty five (45) days of study close-out in all other circumstances unless there is a written agreement between the Trust Board and the Party making payment Sponsor to extend these periods. 10.5 The Party making Sponsor shall make payment shall do so within forty-forty five (45) days of the date of receipt of the invoice mentioned in clause Clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party the Sponsor will incur an interest charge on any amounts overdue of 2 two (2) per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial by the Sponsor are set out in Appendix 6 hereto. 10.2 In the event that amendments to the Protocol require changes to the trial financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 on presentation of a VAT invoice from the Trust Board to the Party making payment. 10.4 The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust Board within 45 days of the close-out of the Trial Site. The Trust Board will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust Board and the Party making payment to extend these periods. 10.5 The Party making payment shall do so within forty-five (45) days of the date of receipt of the invoice mentioned in clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial by the Sponsor are set out in Appendix 6 hereto. 10.2 . In the event that amendments to the Protocol require changes to the trial financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 . All payments will be made according to the schedule contained in Appendix 6 on presentation of a VAT invoice from the Trust Board to the Party making payment. 10.4 . The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust Board within 45 days of the close-out of the Trial Site. The Trust Board will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust Board and the Party making payment to extend these periods. 10.5 . The Party making payment shall do so within forty-five (45) days of the date of receipt of the invoice mentioned in clause 10.3 above. 10.6 . Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial Investigation by the Sponsor are set out in Appendix 6 hereto. 10.2 In the event that amendments to the Protocol Clinical Investigation Plan require changes to the trial investigation financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 5 6 on presentation of a VAT invoice from the Trust to the Party making payment. 10.4 The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust within 45 forty five (45) days of the close-out of the Trial Investigation Site. The Trust will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party Party making payment as soon as possible and, in any event, within 45 forty five (45) days of receipt of the said data where such a request has been made, or within 45 forty five (45) days of study close-out in all other circumstances unless there is a written agreement between the Trust and the Party making payment to extend these periods. 10.5 The Party making payment shall do so within forty-forty five (45) days of the date of receipt of the invoice mentioned in clause Clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial Investigation by the Sponsor are set out in Appendix 6 5 hereto. 10.2 In the event that amendments to the Protocol Clinical Investigation Plan require changes to the trial investigation financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 5 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 5 on presentation of a VAT invoice from the Trust to the Party making paymentSponsor by the Trust. 10.4 The Party making payment Sponsor shall promptly respond to any reasonable request for invoicing data received from the Trust within 45 days of the close-out of the Trial Investigation Site. The Trust will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment Sponsor as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust and the Party making payment Sponsor to extend these periods. 10.5 The Party making Sponsor shall make payment shall do so within forty-forty five (45) days of the date of receipt of the invoice mentioned in clause Clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party the Sponsor will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial Investigation by the Sponsor are set out in Appendix 6 hereto. 10.2 In the event that amendments to the Protocol Clinical Investigation Plan require changes to the trial investigation financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 on presentation of a VAT invoice from the Trust Board to the Party making payment. 10.4 The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust Board within 45 forty five (45) days of the close-out of the Trial Investigation Site. The Trust Board will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party Party making payment as soon as possible and, in any event, within 45 forty five (45) days of receipt of the said data where such a request has been made, or within 45 forty five (45) days of study close-out in all other circumstances unless there is a written agreement between the Trust Board and the Party making payment to extend these periods. 10.5 The Party making payment shall do so within forty-forty five (45) days of the date of receipt of the invoice mentioned in clause Clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial Investigation by the Sponsor are set out in Appendix 6 hereto. 10.2 In the event that amendments to the Protocol Clinical Investigation Plan require changes to the trial investigation financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 5 6 on presentation of a VAT invoice from the Trust NHS Body to the Party making payment. 10.4 The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust NHS Body within 45 forty five (45) days of the close-out of the Trial Investigation Site. The Trust NHS Body will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party Party making payment as soon as possible and, in any event, within 45 forty five (45) days of receipt of the said data where such a request has been made, or within 45 forty five (45) days of study close-out in all other circumstances unless there is a written agreement between the Trust NHS Body and the Party making payment to extend these periods. 10.5 The Party making payment shall do so within forty-forty five (45) days of the date of receipt of the invoice mentioned in clause Clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial Investigation by the Sponsor are set out in Appendix 6 5 hereto. 10.2 In the event that amendments to the Protocol Clinical Investigation Plan require changes to the trial investigation financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 5 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 5 on presentation of a VAT invoice from the Trust to the Party making paymentSponsor by the NHS Body. 10.4 The Party making payment Sponsor shall promptly respond to any reasonable request for invoicing data received from the Trust NHS Body within 45 days of the close-out of the Trial Investigation Site. The Trust NHS Body will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment Sponsor as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust NHS Body and the Party making payment Sponsor to extend these periods. 10.5 The Party making Sponsor shall make payment shall do so within forty-forty five (45) days of the date of receipt of the invoice mentioned in clause Clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party the Sponsor will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Registry Trial by the Sponsor are set out in Appendix 6 5 hereto. 10.2 . In the event that amendments to the Protocol require changes to the trial financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 5 of this Agreement. 10.3 . All payments will be made according to the schedule contained in Appendix 6 5 on presentation of a VAT invoice from the Trust Board to the Party making payment. 10.4 . The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust Board within 45 days of the close-out of the Trial Registry Site. The Trust Board will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust Board and the Party making payment to extend these periods. 10.5 . The Party making payment shall do so within forty-five (45) days of the date of receipt of the invoice mentioned in clause 10.3 above. 10.6 . Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.